๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

RELATIVE BIOAVAILABILITY OF CONTROLLED RELEASE MORPHINE TABLETS (MST CONTINUS) IN CANCER PATIENTS

โœ Scribed by POULAIN, P.; HOSKIN, P. J.; HANKS, G. W.; A-OMAR, O.; WALKER, V. A.; JOHNSTON, A.; TURNER, P.; AHERNE, G. W.

Book ID
126646982
Publisher
Oxford University Press
Year
1988
Tongue
English
Weight
440 KB
Volume
61
Category
Article
ISSN
0007-0912

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Controlled-release morphine tablets in p
Controlled-release morphine tablets in patients with chronic cancer pain : A narrative review of controlled clinical trials
โœ Carol A. Warfield ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 143 KB ๐Ÿ‘ 2 views

## Background: Controlled-release (cr) morphine tablets have become routine therapy in the management of cancer pain. compared with immediate-release (ir) morphine, this formulation provides the benefit of dosing every 12 hours. ## Methods: This study reviewed the 10 published, well controlled, r

Analgesic response to single and multipl
Analgesic response to single and multiple doses of controlled-release morphine tablets and morphine oral solution in cancer patients
โœ Barry R. Goughnour; William W. Arkinstall; John H. Stewart ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 441 KB ๐Ÿ‘ 1 views

Immediate-release oral morphine, given every four hours in individually titrated doses, is effective in the control of severe cancer pain. To evaluate the analgesic efficacy of a controlled-release morphine sulfate preparation, MS Contin tablets (MSC, Purdue Frederick, Toronto, Ontario, Canada), aft